Loyal, a biotech company based in California, has cleared a major hurdle in their quest to bring the first-ever longevity drug for dogs to market. The US FDA found that the drug developed by the company had a reasonable expectation of effectiveness, making it a potential solution to the sad reality of pet ownership where it always feels like we’re forced to say goodbye far too soon. Heather Yourex-West reports.
U.S. News
California-based biotech company clears FDA hurdle in developing longevity drug for dogs
More Videos
-
Gaza crisis: Biden issues ultimatum to Israel over possible Rafah invasion
-
What’s behind the string of tornadoes in the U.S. and could Canada see similar?
-
Tennessee storms: Floods, a tornado, and ‘golf-ball-sized’ hail wreak havoc
-
New York City resident films cruise ship sailing into port with dead whale on it’s bow
-
Gaza crisis: U.S. pauses shipment of weapons to Israel
-
‘No such thing as a perfect parent’: More than half of parents say they’re burned out
You are viewing an Accelerated Mobile Webpage.
View Original Article